Suppr超能文献

非妇科细胞学的外部质量保证:澳大利亚和新西兰的经验。

External quality assurance in nongynecologic cytology: The Australasian experience.

作者信息

Shield Paul W, Frost Felicity, Finnimore Jo L, Wright R Gordon, Cummings Margaret C

机构信息

School of Biomedical Sciences, Faculty of Health, Queensland University of Technology, Brisbane, Queensland, Australia.

Sullivan Nicolaides Pathology, Bowen Hills, Brisbane, Queensland, Australia.

出版信息

Cancer Cytopathol. 2017 May;125(5):349-361. doi: 10.1002/cncy.21838. Epub 2017 Feb 27.

Abstract

BACKGROUND

The Royal College of Pathologists of Australasia Cytopathology Quality Assurance Program has operated an external quality assurance program in nongynecologic cytopathology since 1993. Glass slide preparations of a wide range of nongynecologic cases were circulated to approximately 200 cytopathology laboratories in 16 countries.

METHODS

General nongynecologic cytology cases were manufactured from residual specimens after routine diagnosis. Fine-needle aspiration (FNA) cases were made by sampling fresh tissue and making direct specimens. The majority of cases consisted of both air-dried and fixed preparations. Results returned to laboratories included illustrated case discussions highlighting diagnostic features, key differential diagnoses, and useful adjunctive tests.

RESULTS

The current study reviewed >22,000 results for 123 nongynecologic cases. Cases found to cause the most diagnostic difficulties included serous effusion cases with metastatic carcinoma in a dispersed pattern, well-differentiated carcinoma, and cellular reactive cases; urine specimens with sparse malignant cells; reactive pneumocytes in a bronchoalveolar lavage; breast FNA cases with papillary lesions; gestational specimens; and fibroadenoma. FNA specimens from the lung and thyroid, particularly papillary thyroid carcinoma, generally were well reported.

CONCLUSIONS

The use of multiple preparations of the same specimen has allowed interlaboratory comparison, and the quality assurance program has played an educational role as well as informing the laboratory accreditation process. Cancer Cytopathol 2017;125:349-361. © 2017 American Cancer Society.

摘要

背景

自1993年以来,澳大利亚皇家病理学家学会细胞病理学质量保证计划一直在非妇科细胞病理学领域开展外部质量保证计划。广泛的非妇科病例的玻片标本被分发给16个国家的约200个细胞病理学实验室。

方法

一般非妇科细胞学病例由常规诊断后的剩余标本制成。细针穿刺(FNA)病例通过采集新鲜组织并制作直接标本制成。大多数病例包括空气干燥和固定标本。返回实验室的结果包括附有插图的病例讨论,突出诊断特征、关键鉴别诊断和有用的辅助检查。

结果

本研究回顾了123例非妇科病例的>22,000份结果。发现造成诊断困难最大的病例包括呈分散模式的伴有转移癌的浆液性积液病例、高分化癌和细胞反应性病例;恶性细胞稀少的尿液标本;支气管肺泡灌洗中的反应性肺细胞;伴有乳头状病变的乳腺FNA病例;妊娠标本;以及纤维腺瘤。来自肺和甲状腺的FNA标本,尤其是乳头状甲状腺癌,报告情况总体良好。

结论

对同一样本使用多种标本制备方法有助于实验室间比较,质量保证计划不仅为实验室认可过程提供了信息,还发挥了教育作用。《癌症细胞病理学》2017年;125:349 - 361。©2017美国癌症协会。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验